The use of an oxidative stress scoring system in prognostic prediction for kidney renal clear cell carcinoma

por Wang, Xianjin, Xu, Huan, Guo, Miaomiao, Shen, Yanting, Li, Peizhang, Wang, Zhong, Zhan, Ming
Publicado 2021

Screening to Identify an Immune Landscape-Based Prognostic Predictor and Therapeutic Target for Prostate Cancer

por Shen, Yanting, Xu, Huan, Long, Manmei, Guo, Miaomiao, Li, Peizhang, Zhan, Ming, Wang, Zhong
Publicado 2021

MAFG-AS1 is a prognostic biomarker and facilitates prostate cancer progression

por Li, Peizhang, Shi, Yuanping, Guo, Miaomiao, Xu, Huan, Zhan, Ming, Wang, Zhong, Chen, Yanbo
Publicado 2022

ELK1-mediated YTHDF1 drives prostate cancer progression by facilitating the translation of Polo-like kinase 1 in an m6A dependent manner

por Li, Peizhang, Shi, Yuanping, Gao, Dajun, Xu, Huan, Zou, Yun, Wang, Zhong, Li, Wenzhi
Publicado 2022

E2F transcription factor 2-activated DLEU2 contributes to prostate tumorigenesis by upregulating serum and glucocorticoid-induced protein kinase 1

por Li, Peizhang, Xu, Huan, Yang, Liu, Zhan, Ming, Shi, Yuanping, Zhang, Caoxu, Gao, Dajun, Gu, Meng, Chen, Yanbo, Wang, Zhong
Publicado 2022

Reprogramming hormone-sensitive prostate cancer to a lethal neuroendocrine cancer lineage by mitochondrial pyruvate carrier (MPC)

por Xu, Huan, Liu, Zhixiao, Gao, Dajun, Li, Peizhang, Shen, Yanting, Sun, Yi, Xu, Lingfan, Song, Nan, Wang, Yue, Zhan, Ming, Gao, Xu, Wang, Zhong
Publicado 2022